For phase 3 studies, surrogacy of NfL is not yet defined, and the dynamic range of blood NfL across FTD genotypes will require absolute cutoff levels and/or rates of change defined for each FTD gene mutation population. Here, NEFL is linked to frontotemporal dementia.